US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Birth Control

2,787.82

-24.3853-0.87%

Number of Gainers:3

Number of Losers:2

Number of Flat:- -

PE:- -

High:2,809.85

Open:2,809.06

Low:2,750.09

Close:2,812.21

Volume:1.96M

Turnover:61.02M

Market Cap:46.51B

Float Cap:43.42B

Loading ...

Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ Rasonque™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial

THOMSON REUTERS

Teva Pharmaceuticals : UBS Raises Target Price to $48 from $42

THOMSON REUTERS

Teva Announces Launch of Offering of Senior Notes

THOMSON REUTERS

Femasys registers to sell 28.12M shares of common stock for holders

Femasys - Files for Resale of up to 28,124,997 Shares of Common Stock - SEC Filing

THOMSON REUTERS

Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)

Teva Upgraded to Buy on Strengthening Autoimmune Pipeline and Validating Celiac Disease Data

Veru CEO Steiner to Join Cantor Global Healthcare Conference Fireside Chat

MannKind to Present at Upcoming Investor Conferences

US-Listed Shares of Teva Pharmaceutical up 3.5% Premarket After Co's Immune Disorder Drug Meets Main Goal in Mid-Stage Trial

THOMSON REUTERS

Teva's Stock Jumps over 3% as Immune Disorder Drug Meets Main Goal in Mid-Stage Trial

Teva Pharmaceutical Reports Positive Topline Data for Anti-IL-15 Drug in Celiac Disease

MT Newswires Live

Teva: Tev '408 was Well-Tolerated with no Safety Signals Observed to Date

THOMSON REUTERS

Teva - Tev ‘408 Demonstrates Statistically Significant Prevention of Gluten-Induced Damage in Phase 2a Study

THOMSON REUTERS

Teva - Phase 2a Study Meets Primary Endpoint with Significant Prevention of Gluten-Induced Damage

THOMSON REUTERS

Is Teva Pharmaceutical Industries (TEVA) Undervalued On Its FDA Filing News Or Already Fully Valued?

Simply Wall St.

Introducing Trailpeak: Teva’s First High Performance Daily Trail Running Shoe Co-Created with the Brand’s Bureau of Adventure Athletes

THOMSON REUTERS

White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies

MT Newswires Live

Dow Jones Top Company Headlines at 9 PM ET: Anthropic Signs $35 Billion Cloud Deal Backed by Nvidia | UPS ...

Stocks to Watch: Sono Group, Teva Pharmaceuticals, Pyxis Tankers, Metallus

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigerfiesta.com/stock/BK4584/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4584","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","market":"US","secType":"PLATE","nameCN":"Birth Control","latestPrice":2787.821,"timestamp":1789571225346,"preClose":2812.2063,"halted":0,"volume":1957701,"delay":0,"changeRate":-0.008671,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-24.385254,"latestTime":"09-16 11:07:06 EDT","open":2809.0632,"high":2809.8545,"low":2750.0935,"amount":61015270.992469,"amplitude":0.021251,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":6.012136,"peRate":74.118074,"turnoverRate":0.001363,"increases":3,"decrements":2,"flats":0,"marketCap":46505003735,"floatMarketCap":43421322986},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4584\",,,,,undefined,":{"symbol":"BK4584","high":2809.8545,"amplitude":0.021251,"preClose":2812.2063,"low":2750.0935,"pbRate":"6.012136","latestPrice":2787.821,"volume":1957906,"delay":0,"open":2809.0632,"prevYearClose":2379.9924,"prevWeekClose":2785.0151,"prevMonthClose":2714.4358,"prevQuarterClose":2562.5076,"fiveDayClose":2769.5986,"twentyDayClose":2752.8147,"sixtyDayClose":2433.1455,"secType":"PLATE","market":"US","turnoverRate":0.001363,"peRate":74.118074,"marketCap":46505003735,"floatMarketCap":43421322986,"timestamp":1789571229736,"nameCN":"Birth Control"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4584\",,,,undefined,":{"bkCode":"BK4584","up":3,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4584\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665202933","title":"Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ Rasonque™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2665202933","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665202933?lang=en_us&edition=fundamental","pubTime":"2026-09-08 20:17","pubTimestamp":1788869820,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUAL04RT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["VERU","BK4007","BK4183","BK4584","BK4557"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665039080","title":"Teva Pharmaceuticals : UBS Raises Target Price to $48 from $42","url":"https://stock-news.laohu8.com/highlight/detail?id=2665039080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665039080?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:01","pubTimestamp":1788768098,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nAZN4TIONZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1983299246.USD","BK4584","BK4559","BK4588","BK4007","LU2324357040.USD","BK4557","BK4596","BK4585","BK4566","TEVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665397717","title":"Teva Announces Launch of Offering of Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=2665397717","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665397717?lang=en_us&edition=fundamental","pubTime":"2026-09-07 15:53","pubTimestamp":1788767586,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nTUA6GXFN0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4559","BK4584","BK4557","BK4588","BK4585","BK4007","LU1983299246.USD","TEVA","BK4566","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664041728","title":"Femasys registers to sell 28.12M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2664041728","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664041728?lang=en_us&edition=fundamental","pubTime":"2026-09-04 05:10","pubTimestamp":1788469816,"startTime":"0","endTime":"0","summary":"This filing relates to the offer and sale from time to time by the selling stockholders of up to 28.12M shares of common stock. The company is not ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/femasys-registers-to-sell-28-12m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/femasys-registers-to-sell-28-12m-shares-of-common-stock-for-holders-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4082","FEMY","BK4539","BK4584"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664804981","title":"Femasys - Files for Resale of up to 28,124,997 Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664804981","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664804981?lang=en_us&edition=fundamental","pubTime":"2026-09-04 05:07","pubTimestamp":1788469664,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V18N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","FEMY","BK4584","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664704888","title":"Analysts Are Bullish on Top Healthcare Stocks: Revolution Medicines (RVMD), Teva Pharmaceutical (TEVA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2664704888","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664704888?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:10","pubTimestamp":1788444623,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Revolution Medicines (RVMD) and Teva Pharmaceutical ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-revolution-medicines-rvmd-teva-pharmaceutical-teva-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","IE00B4R5TH58.HKD","BK4557","LU0029874061.USD","BK4581","RVMD","BK4559","IE0009355771.USD","BK4585","IDNA","BK4584","LU1983299246.USD","TEVA","BK4596","XBI","LU0320765992.SGD","HCSG","IE00BJT1NW94.SGD","LU0128526141.USD","LU2324357040.USD","BK4007","XLV","LABU","BK4139","CANC","IE0009354923.USD","BK4566","BK4588","LU0889565916.HKD","PTH","BBH","BK4137","IE0002141913.USD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664884383","title":"Teva Upgraded to Buy on Strengthening Autoimmune Pipeline and Validating Celiac Disease Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2664884383","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664884383?lang=en_us&edition=fundamental","pubTime":"2026-09-03 00:15","pubTimestamp":1788365724,"startTime":"0","endTime":"0","summary":"Evercore ISI analyst Umer Raffat has maintained their bullish stance on TEVA stock, giving a Buy rating on August 31. Umer Raffat has given his Buy...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/teva-upgraded-to-buy-on-strengthening-autoimmune-pipeline-and-validating-celiac-disease-data-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/teva-upgraded-to-buy-on-strengthening-autoimmune-pipeline-and-validating-celiac-disease-data-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4557","BK4584","BK4596","LU1983299246.USD","LU2324357040.USD","BK4588","TEVA","BK4559","BK4566","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664811447","title":"Veru CEO Steiner to Join Cantor Global Healthcare Conference Fireside Chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2664811447","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664811447?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:32","pubTimestamp":1788352326,"startTime":"0","endTime":"0","summary":"Veru CEO Steiner to join Cantor Global Healthcare Conference fireside chatVeru will join the 2026 Cantor Global Healthcare Conference in New York on Sept. 9, 2026.CEO Mitchell Steiner is scheduled for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL5hC4BF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BCDF","SG9999014021.USD","IE00BN0W2T93.GBP","LU2095319765.USD","IE00BN0W2V16.EUR","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4112","BK4585","NDAQ","IE00BQXX3C00.GBP","BK4557","IE00BKPKM429.USD","LU0314104364.USD","SG9999014013.SGD","BK4584","BK4588","IE00BN0W2W23.USD","IE00BQXX3F31.USD","LU2210149790.SGD","BK4007","BK4183","SG9999014039.USD","VERU","IE00BQXX3D17.EUR","LU2210150020.SGD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664581122","title":"MannKind to Present at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2664581122","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664581122?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:30","pubTimestamp":1788352200,"startTime":"0","endTime":"0","summary":"Investor Relations. Kate Miranda. ir@mnkd.com. Media Relations. Christie Iacangelo. media@mnkd.com","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/02/3355137/29517/en/mannkind-to-present-at-upcoming-investor-conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4584","MNKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664190188","title":"US-Listed Shares of Teva Pharmaceutical up 3.5% Premarket After Co's Immune Disorder Drug Meets Main Goal in Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664190188","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664190188?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:10","pubTimestamp":1788351042,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U12J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4584","LU1983299246.USD","BK4559","TEVA","BK4007","BK4585","BK4557","BK4596","BK4566","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664581946","title":"Teva's Stock Jumps over 3% as Immune Disorder Drug Meets Main Goal in Mid-Stage Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2664581946","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664581946?lang=en_us&edition=fundamental","pubTime":"2026-09-02 20:07","pubTimestamp":1788350831,"startTime":"0","endTime":"0","summary":"Teva's immune disorder drug meets main goal in mid-stage trialSept 2 (Reuters)-Israeli drugmaker Teva Pharmaceutical IndustriesTEVA.TA,TEVA.Nsaid on Wednesday its experimental drug helped prevent glut","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nL4N44U0ZO:1","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Teva's Immune Disorder Drug Meets Main Goal in Mid-Stage Trial","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4559","BK4584","IHE","BK4557","LU1983299246.USD","PBE","TEVA","LU2324357040.USD","BK4566","BK4585","BK4596","BK4007","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664638819","title":"Teva Pharmaceutical Reports Positive Topline Data for Anti-IL-15 Drug in Celiac Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2664638819","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664638819?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:51","pubTimestamp":1788349900,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical's  investigational anti-IL-15 antibody TEV '408 met the primary endpoint in an ongoing Phase 2a study in adults with celiac disease, the company said Wednesday.The company said a single subcutaneous dose of TEV '408 demonstrated statistically significant and clinically meaningful prevention of gluten-induced intestinal damage versus placebo at week 8.TEV '408 was well tolerated with no emerging safety signals, and additional analyses are underway, with further data expected to be presented at a future scientific meeting, Teva added.Teva Pharmaceutical shares were up 4.8% in premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2324357040.USD","BK4557","BK4585","BK4007","LU1983299246.USD","BK4584","TEVA","BK4596","BK4566","BK4559","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815493","title":"Teva: Tev '408 was Well-Tolerated with no Safety Signals Observed to Date","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815493","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815493?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:03","pubTimestamp":1788346991,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U0FJ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4557","BK4559","BK4566","BK4007","LU2324357040.USD","BK4584","BK4588","BK4596","BK4585","LU1983299246.USD","TEVA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664815456","title":"Teva - Tev ‘408 Demonstrates Statistically Significant Prevention of Gluten-Induced Damage in Phase 2a Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2664815456","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664815456?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:03","pubTimestamp":1788346991,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U0FJ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BK4585","LU1983299246.USD","TEVA","LU2324357040.USD","BK4557","BK4559","BK4588","BK4584","BK4596","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664431815","title":"Teva - Phase 2a Study Meets Primary Endpoint with Significant Prevention of Gluten-Induced Damage","url":"https://stock-news.laohu8.com/highlight/detail?id=2664431815","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664431815?lang=en_us&edition=fundamental","pubTime":"2026-09-02 19:03","pubTimestamp":1788346991,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44U0FJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4585","LU1983299246.USD","LU2324357040.USD","BK4588","BK4557","TEVA","BK4559","BK4566","BK4596","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664389542","title":"Is Teva Pharmaceutical Industries (TEVA) Undervalued On Its FDA Filing News Or Already Fully Valued?","url":"https://stock-news.laohu8.com/highlight/detail?id=2664389542","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664389542?lang=en_us&edition=fundamental","pubTime":"2026-09-02 11:22","pubTimestamp":1788319331,"startTime":"0","endTime":"0","summary":"Teva Pharmaceutical Industries (NYSE:TEVA) is in focus after the U.S. FDA accepted its New Drug Application for ecopipam, a potential first-in-class treatment for pediatric Tourette syndrome with Orphan Drug and Priority Review status.\nAt a share price of US$36.19, Teva Pharmaceutical Industries has a 1-year total shareholder return of 93.01% and a 5-year total shareholder return of 282.96%. This suggests strong long-term momentum, even after a recent 5.01% decline in the 7-day share price...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/308047-main-header/1585187365850"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/is-teva-pharmaceutical-industries-teva-undervalued-on-its-fd","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nyse-teva/teva-pharmaceutical-industries/news/is-teva-pharmaceutical-industries-teva-undervalued-on-its-fd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2324357040.USD","BK4584","BK4596","BK4585","BK4559","BK4566","BK4588","BK4557","TEVA","BK4007","LU1983299246.USD","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664585193","title":"Introducing Trailpeak: Teva’s First High Performance Daily Trail Running Shoe Co-Created with the Brand’s Bureau of Adventure Athletes","url":"https://stock-news.laohu8.com/highlight/detail?id=2664585193","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664585193?lang=en_us&edition=fundamental","pubTime":"2026-09-01 21:00","pubTimestamp":1788267601,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA59XRGL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4584","BK4559","BK4596","BK4585","BK4566","BK4007","BK4567","BK4557","TEVA","BK4588","LU0266013472.USD","LU2324357040.USD","BK4146","LU1983299246.USD","DECK","STYL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664309048","title":"White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2664309048","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664309048?lang=en_us&edition=fundamental","pubTime":"2026-09-01 17:57","pubTimestamp":1788256679,"startTime":"0","endTime":"0","summary":"The White House made nine new agreements with pharmaceutical manufacturers to bring prescription drug prices for Americans down to the lowest prices paid by other developed nations, it said on Monday.The nine manufacturers include Teva Pharmaceuticals , BridgeBio , Alcon , BeOne Medicines , Astellas Pharma, CSL, Kyowa Kirin, Sun Pharma, and UCB, the White House said.The drugs include treatments for hemophilia, Parkinson's disease, macular degeneration, glaucoma, liver disease, skin conditions, and various forms of cancers, the White House said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ONC","BK4585","LU1983299246.USD","TEVA","LU2324357040.USD","BK7094","BK4139","BK4534","BBIO","BK4559","BK4588","BK4566","ALC.AU","LU2265009873.SGD","BK4596","BK4505","BK4584","BK4198","BK4557","BK4526","BK4007","ALC","ONCO","LU1804176565.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664881085","title":"Dow Jones Top Company Headlines at 9 PM ET: Anthropic Signs $35 Billion Cloud Deal Backed by Nvidia | UPS ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2664881085","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664881085?lang=en_us&edition=fundamental","pubTime":"2026-09-01 09:00","pubTimestamp":1788224400,"startTime":"0","endTime":"0","summary":"Anthropic Signs $35 Billion Cloud Deal Backed by NvidiaNvidia will supply the chips to the Texas data center and hold the lease, again using its financial might to boost a customer.----UPS Rejiggers O","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FAI","LU0300736062.USD","HK0000306685.HKD","SG9999015978.USD","TRUC","LU1934455277.USD","LU2487616109.SGD","LU0976567544.SGD","LU0276348264.USD","LU1804176565.USD","LU0251132253.USD","LU1267930227.SGD","IE000WAW04H5.SGD","OGIG","LU1201861249.SGD","AMZY","LU2756315318.SGD","LU0965509010.AUD","LU2896262040.SGD","LU1803068979.SGD","BK4179","IE00B4JS1V06.HKD","PCG","BK4077","LU2125909247.SGD","LU1037948897.HKD","THMR","LU2237443382.USD","NVDD","KBWP","LU0070217475.USD","HK0000304797.USD","LU1691799644.USD","NVC","ROM","LU1571399168.USD","AMZG","AIFD","LU0211331839.USD","BK4535","BK4592","LU0210533765.USD","LU1868837300.USD","LU2592432038.USD","LU0320765992.SGD","IE00B3QW5Z07.USD","LU0109394709.USD","FBY","LU0251131958.USD","LU2361044949.HKD","LU1989772840.SGD","BK4550","LU2362541513.USD","LU0511384066.AUD","LU1291159041.SGD","SG9999001176.SGD","NVDB","KKR","2NVD.UK","LU2097344357.USD","LU2294711713.HKD","LU2265009873.SGD","XLK","NULC","SG9999014906.USD","LU2097829019.USD","NVDO","BK4503","LU0058720904.USD","LU1821325948.USD","07788","CANC","LU0070302665.USD","LU1854104046.USD","LU2468319806.SGD","NVDW","SG9999003800.SGD","IE00B2B36J28.USD","LU0061474960.USD","IE00B19Z8X17.USD","LU2473716301.USD","LU2213496289.HKD","IE000MB6IJN5.SGD","LU0080751232.USD","LU0158827948.USD","LU0784385840.USD","LU0157215616.USD","LU0823434583.USD","NVDS","LU1935043536.SGD","SHOC","METV","IE00BMPRXQ63.HKD","NVIW.SI","IE00B5949003.HKD","IE0001KFT4U8.USD","IE00BMPRXR70.SGD","LU0127658192.USD","FBL","LU1323610961.USD","LU2125154778.USD","LU1093756168.USD","LU2148611432.USD","LU1400636491.USD","HK0000914686.HKD","IE00BD6J9T35.USD","LU1551013425.SGD","LU2505996509.AUD","LU2054465674.USD","SG9999014880.SGD","LU0882574055.USD","TMED","HK0000914660.USD","LU0689472784.USD","IE0034235303.USD","LU2237957811.SGD","LTL","LU0823411888.USD","IE00BFXG0V08.USD","LU0170899867.USD","BK4585","LU1815333072.USD","LU1914381329.SGD","09388","LU1023059063.AUD","LU0122376428.USD","LU2746668974.SGD","LU0949170772.SGD","LU0097036916.USD","LU1720051017.SGD","LU2420271590.USD","USXF","GB00BDT5M118.USD","SGXZ57979304.SGD","LU0385154629.USD","LU1720051108.HKD","TRUH","SGXZ31699556.SGD","LU2133065610.SGD","LU1645745479.HKD","LU2764263039.SGD","LU1670756490.USD","LU2543165471.USD","LU2065169927.USD","LU2322448957.HKD","LU0471298694.HKD","FCOM","LU0432979614.USD","IE00BQXX3C00.GBP","XDAT","IE00BFSS8Q28.SGD","LU0784385170.HKD","IE0002141913.USD","LU1564329461.SGD","LU1564329628.SGD","LU2089283258.USD","NVII","IE00B1BXHZ80.USD","LU0310800965.SGD","PJP","LU2430703178.SGD","LU1861127337.USD","LU2247934214.USD","LU2317271919.USD","TYLG","LU0069063385.USD","LU1935042488.USD","IE000F7OJYX1.SGD","SMHX","VHT","BK4587","LU2750360997.AUD","LU0496365809.HKD","AMZD","IE00BGHQF748.EUR","LU0683600562.USD","OZEM","LU0345770993.USD","SHPP","SNVD.UK","THNR","BK4596","LU2125909593.SGD","SLB","IE00B64PRP62.GBP","LU2491050071.SGD","XLV","LU0354030511.USD","LU0957808578.USD","LU2360107168.USD","LU3102509885.SGD","IE0004086264.USD","SG9999014898.SGD","LU0444973449.USD","LU2346227817.USD","LU0057025933.USD","SG9999014914.USD","BK4577","FBYY","LU0211328371.USD","LU2860962120.EUR","LU2463028550.USD","LU0823414478.USD","LU2250418816.HKD","GME","LU1564329032.USD","LU2433249047.HKD","LU0353189763.USD","LU2100268510.USD","METQ","CHAT","WISE","LU1979441026.SGD","BK4081","LU1951200564.SGD","BK4076","LU1670627923.USD","TTEQ","IE0004445015.USD","HK0000819398.USD","LU0786609619.USD","IE00BZ1G4Q59.USD","LU2092937148.SGD","AMZW","IE0004445239.USD","GMEY","NVDA","LU0787776722.HKD","LU1429558221.USD","IE00B4YYXB79.USD","SG9999015952.SGD","LU2458330243.SGD","LU1046421795.USD","SOXQ","ONLN","LU1989764664.SGD","LU2237438978.USD","HK0000304805.HKD","SHEL","LU2063271972.USD","LU2552382132.HKD","LU2764262908.HKD","LU1551013342.USD","LU1839511570.USD","IE000BZT7R73.USD","IE00B7SZLL34.SGD","LU1697837992.HKD","SGXZ99366536.SGD","SMH","XLC","LU2108987350.USD","LU1974910355.USD","LU2324357040.USD","TRFK","SGXZ81514606.USD","LU1815336760.USD","SG9999014575.USD","BK4141","LU0068578508.USD","IE00B19Z3B42.SGD","LU0052756011.USD","LU0175139822.USD","LU2242649171.HKD","LU0302445910.USD","IE000M9KFDE8.USD","IE0009356076.USD","LU0353189680.USD","ABFL","LU0133085943.USD","SG9999014542.SGD","IE00BJLML261.HKD","BK4567","LU0433182093.SGD","LU2271345857.HKD","LU1642822529.SGD","NVDU","BK4549","LLYZ","AMZO","LU2506951792.HKD","UPSG","LU2361045086.USD","LU0256863811.USD","HULL","IE00B775H168.HKD","LU1435385759.SGD","LU2720916845.USD","LU1064131342.USD","LU1066051811.HKD","LU1623119135.USD","LU2264538146.SGD","LU0979878070.USD","LU2087621335.USD","METD","PSP","BK4532","LU1267930730.SGD","BK4612","LU0109392836.USD","LU0943347566.SGD","LU0738911758.USD","SG9999014559.SGD","HK0000532082.HKD","LU0784383803.USD","LU2357305700.SGD","AGOX","LU2089284900.SGD","LU0203201768.USD","LU1201861165.SGD","LU1366192091.USD","BK4529","LU0056508442.USD","IE00BDRTCR15.USD","LU0310800379.SGD","LU0308772762.SGD","LU1059921491.USD","LU0528227936.USD","NVYY","PRVT","LU0320765646.SGD","LU0234570918.USD","LU1145028129.USD","LU1127390331.HKD","JGRO","LU2249611893.SGD","LU1868836591.USD","BK4566","BK4559","LU2954938101.SGD","LU2275660780.HKD","IE00BFTCPJ56.SGD","LU0198837287.USD","LU2023250843.SGD","AON","BK4533","LU2272731600.USD","LU2452424414.USD","LU0985320562.USD","SG9999015945.SGD","LU0823421333.USD","LU0965509101.SGD","LU1935043023.USD","LU0719512351.SGD","LU1917777945.USD","LU1823568750.SGD","LU1778281490.HKD","LU2023251221.USD","LU2491050154.USD","LU0061474705.USD","NVDS.UK","LU1084165304.USD","BK4579","IE000Q6AESB8.SGD","IE000W1ABFV2.USD","LU1732799900.SGD","RXL","LU2394011477.USD","PPH","IE0034235295.USD","DOCK","LU2362540622.SGD","LU2430703251.USD","IE000YTNTUN2.SGD","LU2637965513.SGD","META","LU2413666699.HKD","BK4534","LU1852331112.SGD","LU2456880835.USD","ESUM","BK4547","LU0912757837.SGD","LU2065171402.SGD","SGXZ80539844.SGD","LU1791710582.SGD","SUPL","LU0210528500.USD","LU1242518931.SGD","GB00B4LPDJ14.GBP","LU0861579265.USD","SOCL","LU2471134796.USD","LU0823414551.USD","LU2505996681.GBP","LU0130103400.USD","LU0690374961.EUR","LU0345768740.USD","LU1989764748.USD","LU2092627202.USD","IE00BJJMRZ35.SGD","LU2471134952.CNY","LU0456855351.SGD","HK0000320264.USD","LU0882574139.USD","LU1153585028.USD","LU0154236417.USD","LU2237957902.USD","SG9999001077.SGD","LU2237443895.HKD","LU2125154935.USD","LLYX","LU0265550946.USD","LU1670710661.SGD","SG9999000418.SGD","NVDQ","LU0094547139.USD","3NVD.UK","LU0795875169.SGD","RSPC","LU2746668461.USD","LU2083900584.USD","SG9999001424.SGD","LU1489326972.SGD","FDTX","LU0342679015.USD","LU2089984988.USD","LU2211815571.USD","AMZP","LU0871640123.AUD","LU1400636657.SGD","LU1496350171.SGD","VT","LU0114720955.EUR","AMAA","METG","LU1244550221.USD","LU0053666078.USD","LU0081259029.USD","LU1316542783.SGD","BK4201","LLY","CHPX","IE00B4R5TH58.HKD","LU0208291251.USD","LU0187121727.USD","LU1934455194.USD","LU1923622291.USD","LU2065170008.USD","LU2471134523.USD","IE0004091025.USD","LU0203345920.USD","LU1883839398.USD","IE00B3M56506.USD","SG9999015341.SGD","LU2023250504.SGD","SMETAmain","CURE","LU0238689110.USD","DIG","LU1861215975.USD","IE0009G5SDU7.USD","BK4604","LU2112291526.USD","LU0211326755.USD","WDNA","IE0002270589.USD","LU0985489474.SGD","EBAY","LU1066053197.SGD","IE0000B7K699.USD","LU1791807156.HKD","LU2449327464.USD","LU0553294199.USD","LU0345774631.USD","LU0726765562.USD","LU0545039389.USD","NVDL","IE00B775SV38.USD","LU1935042991.SGD","IE0034235188.USD","LU1116320901.HKD","CMAG","LU0211326839.USD","LU1868837136.USD","LU0980610538.SGD","LU0708994859.HKD","IE00B0JY6N72.USD","IE00BFSS7M15.SGD","LU0648000940.SGD","LU0661504455.SGD","NVD3.UK","SPTE","LU0417517546.SGD","FTXH","VGT","LU0320765059.SGD","RTH","MEDX","LU0289739343.SGD","LU0784384876.USD","09788","NVDG","LU2462157665.USD","TEVA","LU0788109477.HKD","LU0347712357.USD","LU1699723380.USD","NVD","ARTY","LU0128525929.USD","LU0471298777.SGD","LU1674673691.USD","LU2362541273.HKD","FBX","LU2931357623.SGD","LU1670711123.USD","CLIX","AZYY","HRTS","IE00B7KXQ091.USD","LU0106261372.USD","LU1670711040.USD","LU0724617625.USD","LU0472753341.HKD","IE00BFXG1179.USD","LU1989772923.USD","LU0316494557.USD","LU1854103824.USD","LU2237443978.SGD","LU1280957306.USD","LU2999663052.SGD","SG9999018857.SGD","IE00BD4GTW91.USD","IE00BN29S564.USD","LU1983260115.SGD","LU1162221912.USD","IXJ","BK4614","LU0077335932.USD","IE00BKDWB100.SGD","SHEH","SG9999001176.USD","LU0552385451.USD","LU0689626769.HKD","LU2125909916.SGD","IE00BMPRXN33.USD","LU1564329115.USD","SNPE","LU0267386448.USD","AGNG","IE00BJTD4N35.SGD","IE00BKPKM429.USD","IE00BHPRN162.USD","LU0300736492.USD","LU0476273544.USD","BK4548","LU1934455863.HKD","LU0823434740.USD","LU2236285917.USD","LU1430594728.SGD","IYT","LU1267930490.SGD","LU0215105999.USD","LU1066051225.USD","LU2750360641.GBP","LU1712237335.SGD","BK4173","TEK","LU1035775433.USD","LU1988902786.USD","LU2272731865.HKD","NVD2.UK","LU2087625088.SGD","TEXU","LU0889565833.HKD","LU1894683264.USD","LU1923623000.USD","LU2089985449.USD","LU2403377893.USD","OIH","IE0009355771.USD","LU2360106947.USD","IE00B19Z8W00.USD","TTXU","LU2028103732.USD","LU0158827781.USD","SOXY","HK0000320223.HKD","LU1992135399.USD","BK4599","IE00BK4W5L77.USD","LU1989771016.USD","USD","LU2552382215.SGD","LU0312595415.SGD","LU2168564149.EUR","LU2047632596.USD","LU2417539215.USD","LU1880398471.USD","LU0708995401.HKD","LU1880398554.USD","AMZN","IYH","LU2326559502.SGD","IE00BJT1NW94.SGD","IE00BQXX3D17.EUR","LU0138981039.USD","IE00BZ199S13.USD","LU1935042215.USD","LU2357125470.USD","BK4557","LU2191332357.HKD","AIPI","SG9999014567.USD","LU1003077747.HKD","LU1629891620.HKD","LU2279689827.SGD","LU2462591350.SGD","LU2168564495.EUR","LU1035773651.USD","ELIL","IE00B3SWFQ91.USD","MEDI","METW","LU0345769631.USD","LU1861559042.SGD","LU2360106780.USD","AMZZ","LU1301847155.USD","LU0203347892.USD","NVDX","SG9999011175.SGD","LU1119994496.HKD","LU0368265418.SGD","LU0266013472.USD","LU2462591277.SGD","SG9999018865.SGD","LU0124676726.USD","LU0211327993.USD","SG9999015986.USD","BK4543","LU0640476718.USD","IE00B3S45H60.SGD","SG9999017495.SGD","LU0130102774.USD","IE00BD4GTV84.USD","LU0109391861.USD","LU2461242641.AUD","LU0048584097.USD","LU0234572021.USD","LU0265550359.USD","LU0096362180.USD","LU2125909759.SGD","SG9999015358.SGD","LU0149725797.USD","LU0162691827.USD","GXPC","LU1633808545.USD","VDE","ANV","SGXZ44715902.SGD","IE00BJJMRX11.SGD","WANT","BK4605","LU1267930573.SGD","LU2237443622.USD","LU1093756325.SGD","IE000KEQY171.SGD","CLSE","LU1242518857.USD","BK4220","LU0106831901.USD","LU0128525689.USD","LU0107464264.USD","BK4598","SGXZ23171101.USD","LU1791710400.SGD","LU2413666426.HKD","LU2552382058.USD","LU0965509283.SGD","LU0390134368.USD","LU0889565916.HKD","LU0320765489.SGD","LU0444971666.USD","LU0072462426.USD","AMZU","ILDR","LU2602419157.SGD","LU2381873111.SGD","LU1983299246.USD","LU1037948541.HKD","UPS","LU0203202063.USD","MHIP","BK4527","LU0820561818.USD","LU2360032135.SGD","LU1261432733.SGD","LU0289739699.SGD","LU1894683348.USD","LU1400636574.HKD","LU0345769128.USD","IE0003U64NQ7.SGD","USAW.SI","LU0345768153.USD","LU1232071149.USD","BK4561","LU2347655073.USD","IE00B19Z3581.USD","LU0072461881.USD","AAUM","LU2237443549.SGD","LU0256331488.USD","BK4551","LU1732800096.USD","LU1992135472.HKD","LU0354030438.USD","GDOC","LU1585245621.USD","IE00BQXX3F31.USD","LLII","LU0557290698.USD","LU1861220033.SGD","LU0274383776.USD","LU0795875086.SGD","LU1861558580.USD","LU0868494708.USD","LU0310799852.SGD","BK4122","GMEC","LU0323239441.USD","IE00B19Z9505.USD","BK4507","LU0942090050.USD","LU2097344431.USD","LU0289961442.SGD","IETC","LU1244550494.USD","LU0225283273.USD","LU1069344957.HKD","BK4135","LU1366333091.USD","SG9999004303.SGD","SGXZ51526630.SGD","LU1814569148.SGD","LU0029864427.USD","LU1718418525.SGD","BK4516","LU0143551892.USD","IE00B1XK9C88.USD","LU0466842654.USD","LU0345770308.USD","LU0868494617.USD","LU1496350502.SGD","BK4554","LU2756315664.SGD","LU0323591593.USD","IE00BK4W5M84.HKD","TEXX","IXN","IE00BDCRKT87.USD","IE00BJJMRY28.SGD","EFIV","LU0289960550.SGD","LU1202635105.USD","GAMR","LU1057294990.SGD","SNVDAmain","LU0648001328.SGD","LU0957791311.USD","LU1066051498.USD","LU1670710588.SGD","LU2491049909.HKD","METU","SG9999002232.USD","IE000ITXATA3.USD","LU0348723411.USD","JDOC","LU0289941410.SGD","BK4584","ESLG","LU0672654240.SGD","SG9999002224.SGD","DIPS","SOXX","LU2272731782.SGD","CNEQ","BK4131","VOX","IE000SO60NU8.SGD","LU1074936037.SGD","LU2211817866.USD","NVDY","LU0345774391.USD","07388","LU0742534661.SGD","LU0823416689.USD","LU1670628061.USD","LU1548497426.USD","LU0079474960.USD","GMEU","LU2471134879.HKD","LU0642271901.SGD","LU0006306889.USD","LU1674673428.USD","LU0314104364.USD","LU1668664300.SGD","LU1721428933.USD","LU0949170426.SGD","LU2111349929.HKD","LU0820562030.AUD","IE00BD4GTT62.SGD","IE00BYXW3230.USD","LU2168563687.JPY","LU2077746001.SGD","LU2458330169.SGD","GPZ","IE00BYQQ9H92.USD","IHE","LU2237443465.HKD","LU1144417596.USD","LU0878866978.SGD","LU0964807845.USD","IGME","LU0823421416.USD","LU0098860793.USD","LU1244550577.SGD","LU0061475181.USD","LU0096364046.USD","LU2322448791.USD","LU2286300806.USD","LU2430703095.HKD","HK0000306701.USD","ELIS","LU2244417387.USD","IE00BKVL7J92.USD","FTEC","BK4524","IE00B5TLWC47.USD","LU2065171311.SGD","LU2347655156.SGD","GB00B4QBRK32.GBP","LU0256863902.USD","LU1923622614.USD","LU2023250330.USD","LU0494093205.USD","LU0210536198.USD","BK4007","FHLC","LU2404859667.USD","LU1061106388.HKD","LU1868836914.USD","LU2404859741.USD","BK4608","LFGY","LU0174119429.USD","LU2361044865.SGD","IE0005OL40V9.USD","LU2290526834.HKD","LU0251142724.SGD","LU1951198990.SGD","LU1069347547.HKD","IE00BWXC8680.SGD","LU0122379950.USD","SG9999013999.USD","LU2764263203.CNY","LU0278409577.USD","IE00BJTD4V19.USD","LBO","LU1868836757.USD","LU2168564222.USD","BK4588","LU0820561909.HKD","LU0048573561.USD","LU0965508806.USD","LU0323240290.USD","BK4581","IEZ","LU1116320737.USD","LU0395794307.EUR","LU0082616367.USD","BK4538","LU2168564065.EUR","LU0690374615.EUR","LU1235294995.USD","LU0011850046.USD","LU2106854487.HKD","LU2242650005.HKD","SAMZNmain"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664886205","title":"Stocks to Watch: Sono Group, Teva Pharmaceuticals, Pyxis Tankers, Metallus","url":"https://stock-news.laohu8.com/highlight/detail?id=2664886205","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664886205?lang=en_us&edition=fundamental","pubTime":"2026-09-01 07:35","pubTimestamp":1788219300,"startTime":"0","endTime":"0","summary":"Sono Group signed a nonbinding letter of intent to merge with Sports One. The stock surged 79% to $4.80 in after-hours trading on Monday.Teva Pharmaceuticals was among nine companies to reach most-favored-nation drug pricing agreements with the Trump administration. Shares gained 2.4% to $36.90 after the market closed.Pyxis Tankers swung to a second-quarter profit as higher shipping demand lifted the company's top line. The stock jumped 13% to $6.05.Metallus said Chief Executive Michael Williams plans to retire at the end of the year and will be succeeded by Chief Operating Officer Kristopher Westbrooks. Shares were off 3.6% at $18.81.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MTUS","BK4124","BK4596","BK4566","TEVA","BK4007","BK4557","BK4559","BK4584","BK4588","BK4021","BK4006","LU1983299246.USD","LU2324357040.USD","PXS","PXSAW","SSM","BK4585"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":41,"code":"91000000","status":"200"}]}}